{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:13:49Z","timestamp":1791288829823,"version":"4.3.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.msard.2022.103722","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T21:23:02Z","timestamp":1646860982000},"page":"103722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Pharmacological treatment of tremor in multiple sclerosis; a systematic review"],"prefix":"10.1016","volume":"60","author":[{"given":"Ahmad","family":"Pourmohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Mohsen","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4409-9404","authenticated-orcid":false,"given":"Iman","family":"Adibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.103722_bib0001","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/J003v17n03_06","article-title":"Interference of upper limb tremor on daily life activities in people with multiple sclerosis","volume":"17","author":"Feys","year":"2004","journal-title":"Occup. Ther. Health Care"},{"key":"10.1016\/j.msard.2022.103722_bib0002","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/brain\/124.4.720","article-title":"A study of tremor in multiple sclerosis","volume":"124","author":"Alusi","year":"2001","journal-title":"Brain\u00a0A J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0003","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00415-006-0296-7","article-title":"Tremor in multiple sclerosis","volume":"254","author":"Koch","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006714","article-title":"Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey","volume":"5","author":"Rinker","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.msard.2022.103722_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10100722","article-title":"Tremor in multiple sclerosis-an overview and future perspectives","volume":"10","author":"Makhoul","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.msard.2022.103722_bib0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00415-006-0296-7","article-title":"Tremor in multiple sclerosis","volume":"254","author":"Koch","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005029.pub2","article-title":"Treatment for ataxia in multiple sclerosis","author":"Mills","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.msard.2022.103722_bib0008","article-title":"Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment","volume":"2","author":"Labiano-Fontcuberta","year":"2012","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"10.1016\/j.msard.2022.103722_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/ner.13063","article-title":"Deep brain stimulation for multiple sclerosis tremor: a meta-analysis","author":"Brandmeir","year":"2020","journal-title":"Neuromodulation"},{"key":"10.1016\/j.msard.2022.103722_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103256","article-title":"Deep brain stimulation for multiple sclerosis tremor: a systematic review and meta-analysis","volume":"56","author":"Zali","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103722_bib0011","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.msard.2022.103722_bib0012","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/WNL.35.9.1374","article-title":"Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis","volume":"35","author":"Hallett","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103722_bib0013","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00314007","article-title":"A controlled trial of isoniazid therapy for action tremor in multiple sclerosis","volume":"234","author":"Bozek","year":"1987","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0014","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/jnnp.62.3.282","article-title":"Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor","volume":"62","author":"Rice","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.103722_bib0015","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00415-003-0176-3","article-title":"Double-blind crossover study with dolasetron mesilate, a 5-HT3 receptor antagonist in cerebellar syndrome secondary to multiple sclerosis","volume":"250","author":"Monaca-Charley","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0016","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1212\/01.WNL.0000118203.67138.3E","article-title":"The effect of cannabis on tremor in patients with multiple sclerosis","volume":"62","author":"Fox","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103722_bib0017","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103722_bib0018","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/1352458508099142","article-title":"The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis","volume":"15","author":"Feys","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103722_bib0019","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1212\/WNL.0b013e31825dcdd9","article-title":"A double-blind, randomized, controlled study of botulinum toxin type a in MS-related tremor","volume":"79","author":"Van Der","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103722_bib0020","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/ene.14403","article-title":"Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study","volume":"27","author":"Solaro","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0021","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1468-1331.2008.02129.x","article-title":"Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: A pilot kinematic study","volume":"15","author":"Solaro","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101984","article-title":"OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas","volume":"40","author":"Boonstra","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103722_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2022.103722_bib0024","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/jnnp.2005.070136","article-title":"Cannabinoids in multiple sclerosis (CAMS) study: Safety and efficacy data for 12 months follow up","volume":"76","author":"Zajicek","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.103722_bib0025","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/WNL.32.8.912","article-title":"Treatment of action tremor in multiple sclerosis with isoniazid","volume":"32","author":"Sabra","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103722_bib0026","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/WNL.35.12.1772","article-title":"Isoniazid for tremor in multiple sclerosis: a controlled trial","volume":"35","author":"Duquette","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103722_bib0027","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/jnnp.48.3.282","article-title":"Isoniazid and action tremor in multiple sclerosis","volume":"48","author":"Morrow","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.103722_bib0028","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jnnp.49.1.87","article-title":"The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry","volume":"49","author":"Francis","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.103722_bib0029","article-title":"Cannabis and cannabinoids for people with multiple sclerosis","author":"Filippini","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.msard.2022.103722_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11910-018-0814-x","article-title":"The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews","volume":"18","author":"Nielsen","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.msard.2022.103722_bib0031","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.410130616","article-title":"Tetrahydrocannabinol for tremor in multiple sclerosis","volume":"13","author":"Clifford","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0032","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00314410","article-title":"Effect of cannabinoids on spasticity and ataxia in multiple sclerosis","volume":"236","author":"Meinck","year":"1989","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0033","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00415-006-0112-4","article-title":"Levetiracetam for cerebellar tremor in multiple sclerosis - an open-label pilot tolerability and efficacy study","volume":"253","author":"Striano","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0034","first-page":"S78","article-title":"Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis","volume":"18","author":"Chitsaz","year":"2013","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.msard.2022.103722_bib0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0278-5846(03)00170-2","article-title":"Effects of topiramate in patients with cerebellar tremor","volume":"27","author":"Sechi","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.msard.2022.103722_bib0036","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/WNF.0b013e3181f84a39","article-title":"Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case report","volume":"33","author":"Schroeder","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.msard.2022.103722_bib0037","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1034\/j.1600-0404.2001.00075.x","article-title":"Failure of ondansetron in treating cerebellar tremor in MS patients\u2013an open-label pilot study","volume":"104","author":"Gbadamosi","year":"2001","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2022.103722_bib0038","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1468-1331.1997.tb00301.x","article-title":"Botulinum toxin type a in cerebellar tremor caused by multiple sclerosis","volume":"4","author":"Clarke","year":"1997","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0039","first-page":"720","article-title":"Primidone as a treatment for cerebellar tremor in multiple sclerosis\u2013two case reports","volume":"25","author":"Henkin","year":"1989","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.msard.2022.103722_bib0040","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/WNF.0b013e31826249bb","article-title":"The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosis","volume":"35","author":"Naderi","year":"2012","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.msard.2022.103722_bib0041","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/1352458512461394","article-title":"Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report","volume":"19","author":"Schniepp","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2022.103722_bib0042","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archneur.1991.00530170077023","article-title":"Glutethimide treatment of disabling action tremor in patients with multiple sclerosis and traumatic brain injury","volume":"48","author":"Aisen","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0043","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/archneur.1984.04050150058017","article-title":"Pharmacologic trials in the treatment of cerebellar tremor","volume":"41","author":"Koller","year":"1984","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0044","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/archneurol.2007.13","article-title":"Ethanol responsive tremor in a patient with multiple sclerosis","volume":"65","author":"Hammond","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2022.103722_bib0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jns.2015.09.360","article-title":"Tremor in multiple sclerosis: the intriguing role of the cerebellum","volume":"358","author":"Ayache","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2022.103722_bib0046","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00702-017-1798-4","article-title":"Tremor in multiple sclerosis is associated with cerebello-thalamic pathology","volume":"124","author":"Boonstra","year":"2017","journal-title":"J. Neural Trans."},{"key":"10.1016\/j.msard.2022.103722_bib0047","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/1352458519837706","article-title":"Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis","volume":"26","author":"Bonstra","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103722_bib0048","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.22416","article-title":"Thalamic stimulation restores defective cerebellocortical inhibition in multiple sclerosis tremor","volume":"24","author":"Ayache","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.msard.2022.103722_bib0049","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/01.WNL.0000137419.85535.C7","article-title":"Thalamic deep brain stimulation activates the cerebellothalamocortical pathway","volume":"63","author":"Molnar","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103722_bib0050","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/01.wnr.0000176521.26971.58","article-title":"Relationship between multiple sclerosis intention tremor severity and lesion load in the brainstem","volume":"16","author":"Feys","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.msard.2022.103722_bib0051","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/mds.870080218","article-title":"MR imaging findings of tremors associated with lesions in cerebellar outflow tracts: report of two cases","volume":"8","author":"Nakamura","year":"1993","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.msard.2022.103722_bib0052","doi-asserted-by":"crossref","first-page":"e01039","DOI":"10.1002\/brb3.1039","article-title":"White matter measures correlate with essential tremor severity\u2014a pilot diffusion tensor imaging study","volume":"8","author":"Nestrasil","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.msard.2022.103722_bib0053","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1212\/WNL.0000000000006694","article-title":"White matter differences between essential tremor and Parkinson disease","volume":"92","author":"Juttukonda","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103722_bib0054","first-page":"ONS","article-title":"Dual electrode thalamic deep brain stimulation for the treatment of posttraumatic and multiple sclerosis tremor","volume":"58","author":"Foote","year":"2006","journal-title":"Op. Neurosurg."},{"key":"10.1016\/j.msard.2022.103722_bib0055","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/brain\/124.4.720","article-title":"A study of tremor in multiple sclerosis","volume":"124","author":"Alusi","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.msard.2022.103722_bib0056","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/mds.20227","article-title":"Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted county population","volume":"19","author":"Pittock","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.msard.2022.103722_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2014.04.001","article-title":"Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab","author":"Rinker","year":"2014","journal-title":"Mult. Sclero. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822002371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822002371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:01:38Z","timestamp":1761901298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822002371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":57,"alternative-id":["S2211034822002371"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103722","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatment of tremor in multiple sclerosis; a systematic review","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103722"}}